Current and historical daily PE Ratio for Rafael Holdings Inc (
) from 2018 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Rafael stock (RFL) PE ratio as of Jun 08 2024 is 15.
More Details
Rafael Holdings Inc (RFL) PE Ratio (TTM) Chart
Rafael Holdings Inc (RFL) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1226
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Rafael PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 15.0 | 2024-04-05 | 17.3 |
| 2024-06-07 | 15.0 | 2024-04-04 | 17.4 |
| 2024-06-06 | 15.2 | 2024-04-03 | 17.8 |
| 2024-06-05 | 15.4 | 2024-04-02 | 17.2 |
| 2024-06-04 | 15.8 | 2024-04-01 | 17.5 |
| 2024-06-03 | 15.7 | 2024-03-28 | 17.2 |
| 2024-05-31 | 15.3 | 2024-03-27 | 17.2 |
| 2024-05-30 | 15.3 | 2024-03-26 | 17.1 |
| 2024-05-29 | 15.3 | 2024-03-25 | 16.9 |
| 2024-05-28 | 15.7 | 2024-03-22 | 17.1 |
| 2024-05-24 | 15.9 | 2024-03-21 | 17.1 |
| 2024-05-23 | 15.7 | 2024-03-20 | 17.3 |
| 2024-05-22 | 15.7 | 2024-03-19 | 16.8 |
| 2024-05-21 | 16.0 | 2024-03-18 | 17.0 |
| 2024-05-20 | 16.4 | 2024-03-15 | 17.3 |
| 2024-05-17 | 16.0 | 2024-03-14 | 17.2 |
| 2024-05-16 | 15.9 | 2024-03-13 | 16.7 |
| 2024-05-15 | 15.6 | 2024-03-12 | 16.6 |
| 2024-05-14 | 15.9 | 2024-03-11 | 16.8 |
| 2024-05-13 | 16.0 | 2024-03-08 | 17.3 |
| 2024-05-10 | 16.0 | 2024-03-07 | 17.1 |
| 2024-05-09 | 15.9 | 2024-03-06 | 17.0 |
| 2024-05-08 | 16.1 | 2024-03-05 | 17.1 |
| 2024-05-07 | 16.0 | 2024-03-04 | 17.2 |
| 2024-05-06 | 15.9 | 2024-03-01 | 17.2 |
| 2024-05-03 | 16.2 | 2024-02-29 | 17.2 |
| 2024-05-02 | 16.2 | 2024-02-28 | 17.3 |
| 2024-05-01 | 16.2 | 2024-02-27 | 17.4 |
| 2024-04-30 | 15.9 | 2024-02-26 | 17.3 |
| 2024-04-29 | 17.2 | 2024-02-23 | 17.1 |
| 2024-04-26 | 17.1 | 2024-02-22 | 17.6 |
| 2024-04-25 | 17.1 | 2024-02-21 | 18.3 |
| 2024-04-24 | 17.1 | 2024-02-20 | 18.3 |
| 2024-04-23 | 17.1 | 2024-02-16 | 18.7 |
| 2024-04-22 | 17.4 | 2024-02-15 | 18.6 |
| 2024-04-19 | 17.6 | 2024-02-14 | 19.1 |
| 2024-04-18 | 17.1 | 2024-02-13 | 19.2 |
| 2024-04-17 | 17.8 | 2024-02-12 | 19.2 |
| 2024-04-16 | 18.0 | 2024-02-09 | 18.4 |
| 2024-04-15 | 18.2 | 2024-02-08 | 18.2 |
| 2024-04-12 | 16.6 | 2024-02-07 | 18.6 |
| 2024-04-11 | 16.8 | 2024-02-06 | 18.7 |
| 2024-04-10 | 16.7 | 2024-02-05 | 18.4 |
| 2024-04-09 | 16.9 | 2024-02-02 | 18.3 |
| 2024-04-08 | 17.3 | 2024-02-01 | 18.3 |
Rafael Holdings Inc (RFL) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Rafael Holdings Inc
NAICS : 531110
SIC : 6519
ISIN : US75062E1064
Share Class Description:
RFL: Ordinary Shares - Class BDescription
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers